ALISO VIEJO, Calif.--(BUSINESS WIRE)--Valeant Pharmaceuticals International (NYSE:VRX) today announced that it has filed with the United States Securities and Exchange Commission (SEC) an amended annual report on Form 10-K for the year ended December 31, 2005. The company also filed its quarterly report on Form 10-Q for the quarter ended September 30, 2006. The company expects to file its amended quarterly reports on Form 10-Q for the quarters ended March 31, 2006 and June 30, 2006 in the next few days.
